This is the authors' abstract. We don't add key points for this paper.
This research aims to elucidate the therapeutic potential of polyphenol–protein particle‐enriched beverages in the rat model of acetic acid‐induced colitis. The 50 male Wistar rats were divided into five groups: G 0 as the negative control, G 1 as the positive control, G 2 as the standard drug group (mesalamine 500 mg/kg), G 3 as the group receiving the control beverage (without particle enrichment), and G 4 as the group receiving the enriched beverage (0.15 mL/day/rat). The study duration was 21 days. Polyphenol–protein particle‐enriched beverage ameliorated the disease activity index (DAI), weight loss, and colon weight‐to‐length ratio. Furthermore, it witnessed a reduction in ESR and CRP levels and improved hematological parameters. The following serum inflammatory markers were also decreased: TNF‐α (49.52%), IL‐1β (46.13%), and IL‐6 (55.72%). The oxidative stress was alleviated by reducing the levels of TOS (64.10%), MDA (40.71%), and MPO (83.32%) while enhancing the TAC (191.55%), GSH (47.89%), SOD (87.89%), and CAT (63.63%) levels. The polyphenol–protein‐enriched beverage was also safe in terms of its effect on liver and kidney function markers. Also, polyphenol–protein particle‐enriched beverage exerted regeneration in the histological damage in the colon. Bioaccessibility studies revealed higher total phenolic content and antioxidant activity in the digested fraction of the enriched beverage.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tul‐Muntaha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: